Metrics Appoints New Vice-President - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Metrics Appoints New Vice-President


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 1

Metrics has appointed John Ross as executive vice-president. In his new role, Ross is responsible for managing and expanding Metrics’ fee-for-service operations. The company’s contract services include pharmaceutical oral dose formulation development with suites for potent-product handling, clinical trial materials manufacturing, analytical testing method development and validation, stability studies, and other laboratory support services.

Ross’s 20 years of managerial experience include serving as COO and leading US and Canadian operations at CPL, a contract manufacturing organization for liquid and semisolid pharmaceutical products headquartered in Canada.

Source: Metrics

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here